ZBED2¿¹Ìå¾ICC, IHCÑϸñÑéÖ¤,Æ·Öʱ£Ö¤.ÊÊÓÃÓÚ¶àÖÖÖÖÊô·´Ó¦ÐÔ,±»¶àƪÎÄÏ×ÒýÓò¢ÓÐÓû§·´À¡ÐÅÏ¢.È·±£ÌØÒìÐÔ!²úÎï¾ßÓÐÒÔÏÂÌØµã:
1¡¢È«£ºÍøÂçÈ«ÊÀ½çµÄÉϵȲúÎ»ù±¾Éϸ÷ÖÖ¿¹Ìå²úÎïÔڸù«Ë¾¾ùÄÜÕÒµ½
2¡¢Ð£º²úÎï¼°ÍøÕ¾¸üзdz£¿ì£¬»ù±¾ÉÏÿÖܾùÓÐвúÎï³öÏÖ
3¡¢ÓÅ£º²úÎïÖÊÁ¿ºÃ£¬Í¶Ë߱ȽÏÉÙ
4¡¢Ç¿£ºÇ¿´óµÄ¼¼ÊõÖ§³Ö¶ÓÎéºÍÁ¦Á¿£¬ÍøÕ¾ÉÏÓÐÆëÈ«µÄ¼¼Êõ×ÊÁÏÒÔ¼°¿Í»§ÆÀÂÛ£¬²¢ÌṩʵʱÔÚÏß¼¼Êõ×Éѯ£¬Ê¹ÄúʹÓòúÎïʱûÓÐÈκκó¹ËÖ®ÓÇ¡£
²úÎï±àºÅxy-13552R
Ó¢ÎÄÃû³Æ´Üµþ·¡¶Ù2
ÖÐÎÄÃû³ÆÐ¿Ö¸µ°°×µþ·¡¶Ù¿¹Ìå
±ð ÃûMGC10796; ZBED2; ZBED2_HUMAN; Zinc finger BED domain containing protein 2; Zinc finger BED domain-containing protein 2; Zinc finger, BED domain containing 2.
˵ Ã÷ Êé100ul 200ul
Ñо¿ÁìÓòϸ°ûÉúÎï пָµ°°× ±í¹ÛÒÅ´«Ñ§
¿¹ÌåÀ´Ô´¸é²¹²ú²ú¾±³Ù
¿Ë¡ÀàÐͱʴDZô²â³¦±ô´Ç²Ô²¹±ô
ZBED2¿¹Ìå½»²æ·´Ó¦ Human, Cow, Sheep,
²úÎïÓ¦ÓÃWB=1:500-2000 ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:400-800 ICC=1:100-500 IF=1:100-500 £¨Ê¯À¯ÇÐÆ¬Ðè×ö¿¹ÔÐÞ¸´£©
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
·Ö ×Ó Á¿25kDa
ÐÔ ×´Lyophilized or Liquid
Ũ ¶È1mg/1ml
Ãâ Òß ÔKLH conjugated synthetic peptide derived from human ZBED2
ÑÇ ÐÍIgG
´¿»¯·½·¨affinity purified by Protein A
´¢ ´æ Òº0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
±£´æÌõ¼þStore at -20 ¡ãC for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20¡ãC. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 ¡ãC.
PubMedPubMed
²úÎï½éÉܲú²¹³¦°ì²µ°ù´Ç³Ü²Ô»å:
ZBED3 is an Axin-binding protein involved in Wnt/beta-catenin signaling modulation. ZBED4 expression has been shown in human and mouse retinas where it is thought to act as a regulatory protein in cone photoreceptors and M¨¹ller cells. The functions of ZBED2 and ZBED5 have yet to be elucidated.
Similarity:
Contains 1 BED-type zinc finger.
SWISS:
Q9BTP6
Gene ID:
79413
¿¹ÌåÑ¡ÔñÖ¸ÄÏ
ZBED2¿¹Ìå¼ì²âÈκÎÄ¿µÄ°Ðµ°°×¶¼Óв»Ö¹Ò»ÖÖ¿¹Ìå¿É¹©Ñ¡Ôñ£¬ÎªËõС¿¹ÌåµÄÑ¡Ôñ·¶Î§Ñ¡ÖкÏÊʵĿ¹Ì壬ÐèÒª¿¼ÂÇÈçϼ¸ÖÖÒòËØ£º
£¨1£© ·ÖÎö»òÓ¦ÓõÄÀàÐÍ
£¨2£©Ñù±¾µ°°×µÄ½á¹¹ÐÔÖÊ
£¨3£©Ñù±¾µÄÖÖÊô
£¨4£©¿¹ÌåËÞÖ÷µÄÖÖÀà
£¨5£©¿¹ÌåµÄ±ê¼ÇºÍ¼ì²â
1 ·ÖÎöÊÔÑéµÄÓ¦ÓÃÀàÐÍÒ»°ã¿¹Ìå˵Ã÷Êé¶¼Áгö¸Ã¿¹Ìå¾ÊÔÑéÑéÖ¤¹ýÊÊÓÃÓÚºÎÖÖ·ÖÎöÀàÐÍ£¬È磺
¿ÉÒÔÓ¦ÓÃÓÚWB IHC ICC ELASA ·ÖÎöµÈ£¬Èç¹û¿¹Ìå˵Ã÷ÊéûÓÐÌá¼°µÄÓ¦ÓÃÀàÐÍ£¬²¢²»Òâζןÿ¹Ìå²»ÊÊÓÃÓÚ´ËÖÖ·ÖÎöÓ¦ÓÃÀàÐÍ£¬¶ø½öÊÇ˵Ã÷ÉÐδ¾¹ý´ËÖÖ·ÖÎöÊÔÑéÑéÖ¤£¬Èç¹û¿¹Ìå²»ÊÊÓÃijЩ·ÖÎöÊÔÑ飬Ôò»áÔÚ¿¹Ìå˵Ã÷ÊéÉϱê×¢³öÀ´²»ÊÊÓÚij·ÖÎöÊÔÑé¡£
2 Ñù±¾µ°°×µÄ½á¹¹ÐÔÖÊÁ˽âÑù±¾µ°°×µÄ½á¹¹ÐÔÖÊÓÐÖúÓÚÑ¡Ôñ*ºÏÊʵĿ¹Ì壬ÖÁÉÙÐèÒª¿¼ÂÇÁ½·½ÃæÒòËØ
(1)..´ý²âÑù±¾µ°°×µÄ½á¹¹Óò£ºZBED2¿¹ÌåÊÇÓɸ÷ÖÖ²»Í¬**Ô**ËÞÖ÷¶øÖƱ¸µÃÀ´£¬ÆäÖеÄ**Ô°üÀ¨£ºÈ«³¤µ°°×¡¢µ°°×Ƭ¶Ï¡¢¶àëÄ¡¢È«ÓлúÌ壨È磺**£©»òϸ°û£¬¿¹Ìå˵Ã÷ÊéÒ»°ã¶¼ÓÐ**ÔµÄÃèÊö£¬Èç¹û´òËã¼ì²âµÄÊǵ°°×Ƭ¶Ï»òÒ»ÖÖÌØÊâµÄͬÐÍÎï»òµ°°×È«³¤µÄÄ³Ò»ÇøÓò£¬Ôò±ØÐëÑ¡ÔñÓú¬´ËƬ¶ÎÓòµÄ**ÔÖÆ±¸³öµÄ¿¹Ìå¡£Èç¹û´òËãÓÃFACS Á÷ʽ¼ì²â»îϸ°ûµÄ±íÃæµ°°×£¬ÔòÐèҪѡÔñº¬¸Ã±íÃæµ°°×µÄ°ûÍâÓòÀ´**ÖÆ±¸µÄ¿¹Ìå¡£
(2)Ñù±¾µÄÌáÈ¡»ò´¦Àí¹ý³Ì£ºÄ³Ð©¿¹ÌåÒªÇóÑù±¾¾¹ýÄ³Ð©ÌØÊâ´¦Àí£¬ÀýÈ磺Ðí¶à¿¹Ìåֻʶ±ð»¹ÔºÍ±äÐԵġ¢±íλÒѱ©Â¶²»Êܶþ¼¶Ëļ¶½á¹¹×谵ĵ°°×Ñù±¾£¬ÁíÒ»·½Ã棬ijЩ¿¹Ìå½öʶ±ðÌìÈ»ÕÛµü״̬µÄµ°°×¡£
µ±Ñ¡Ôñ**×黯µÄ¿¹Ìåʱ£¬Ó¦×¢ÒâijЩ¿¹Ìåֻʶ±ðδ¹Ì¶¨µÄÀä¶³µÄ×éÖ¯£¬¶øÁíһЩ¿¹ÌåÔòÊÊÓÃÓÚÎÞÐ迹ÔÐÞ¸´½â½»Áª²½¾ÛµÄ¼×È©¹Ì¶¨Ê¯À¯°üÂñµÄ×éÖ¯£¬ÕâЩ¶¼»áÔÚ¿¹Ìå˵Ã÷ÊéÉÏÓ¦Óò¿·Ö±êʾ³öÀ´ 3 Ñù±¾µÄÎïÖÖ Ó¦Ñ¡ÔñÎïÖÖÏàͬ»òÓн»²æ·´Ó¦µÄ¿¹Ì壬¿¹Ìå¿ÉÄÜÓ벻ͬÎïÖÖµÄͬÖְе°°×Óн»²æ·´Ó¦£¬ÒòÆä°±»ùËáÐòÁÐͬԴÐԽϸߡ£
Èç¹ûÑù±¾µÄÖÖÀàδÁÐÈ뿹Ìå˵Ã÷ÊéÉϵĽ»²æ·´Ó¦ÖÖÊô±íÖУ¬²¢²»Òâζןÿ¹Ìå²»ÊÊÓÃÓÚ¼ì²â¸ÃÎïÖֵĵ°°×£¬¶øÖ»ÊDZíʾ¸ÃÎïÖÖÉÐδÓô˿¹Ìå¼ì²âÑéÖ¤¹ý£¬Ó¦Í¨¹ýÐòÁбȶԵķ½·¨À´Ô¤²â½»²æ·´Ó¦£¬ZBED2¿¹Ìå¿ÉÓ¦ÓÃExpasy ºÍ NCBI BLAST À´½øÐв»Í¬ÎïÖÖµ°°×ͬԴÐԱȶԡ£
4 Ò»¿¹ËÞÖ÷ÎïÖÖµÄÑ¡ÔñÒ»°ã˵À´£¬ÔÚʹÓÃżÁª¶þ¿¹½áºÏÎÞżÁªÎïµÄÒ»¿¹Ê±£¬Ò»¿¹ËÞÖ÷¶¯ÎïµÄÎïÖÖÑ¡Ôñ½ÏÎªÖØÒª£¬¶ÔÓÚ**×黯¶øÑÔ£¬¾¡¿ÉÄÜÑ¡ÔñÓëÑù±¾²»Í¬ÖÖϵÎïÖÖµÄÒ»¿¹£¬´Ó¶ø±ÜÃâ¶þ¿¹ÓëÑù±¾ÄÚÔ´ÐÔ**Çòµ°°×²úÉú½»²æ·´Ó¦£¬
ÀýÈ磺¼ì²âСÊóÑù±¾µ°°×£¬Ôò²»Ó¦Ñ¡ÔñСÊó»ò´óÊóÔ´µÄÒ»¿¹£¬*ºÃÑ¡ÍÃÔ´µÄÒ»¿¹£¬Ôò¶þ¿¹Ôò¿ÉÑ¡ÔñżÁªÁ˼ì²â·Ö×Ó£¨Ã¸¡¢Ó«¹âËØ¡¢ÉúÎïËØµÈ£©µÄ¿¹ÍÃIgG¡£Èç¹ûÑ¡ÔñÓÐżÁªÎïµÄÒ»¿¹Ôò²»ÊÊÓÃÉÏÊöÇé¿ö£¬³ý**×黯ÍâµÄÆäËü¶Ô²»º¬ÄÚÔ´ÐÔ**Çòµ°°×Ñù±¾µÄ¼ì²â·½·¨£¬Ôò¿¹ÌåËÞÖ÷ÎïÖÖµÄÓ°Ïì²»´ó£¬Èç¶Ô²»º¬IgG µÄϸ°ûÁѽâÎïÑù±¾µÄwestern blotting¼ì²â¡£
¾¡¹ÜÈç´Ë£¬ZBED2¿¹Ì庬ÓÐѪÇåµÄ×éÖ¯ÁѽâÎïºÍ×éÖ¯ÅàÑøÉÏÇåÖк¬ÓÐ**Çòµ°°×£¬»¹Ô±äÐÔÑù±¾Öк¬IgG£¬ÔÚwestern blot ¼ì²âÖÐÔò½áºÏ³öÏÖIgG ·Ö×Ó50 and 25 kDa µÄÖØÁ´ºÍÇáÁ´Ìõ´ø¡£
5 ¶þ¿¹µÄÑ¡Ôñ ¶þ¿¹Ó¦Ñ¡ÓÃÓëʹÓõÄÒ»¿¹ÏàͬµÄÎïÖÖÀ´Ô´£¬ÀýÈ磺Èç¹ûÄãµÄÒ»¿¹ÊÇСÊóµÄµ¥¿Ë¡¿¹Ì壬¶þ¿¹ÔòÑ¡¿¹Ð¡ÊóµÄ¶þ¿¹anti-mouse secondary¡£½¨Òé¼ì²é¶þ¿¹ËµÃ÷ÊéÈ·±£¸Ã¿¹ÌåÊÊÓÃÓÚÄãµÄ¼ì²âÓ¦Ó㬠¶þ¿¹Ò»°ãÁ¬½ÓÓ«¹âËØFITC »ò·¢¹âÍÅ¡£
6 Ë«ÖØÈ¾É«¿¹ÌåµÄÑ¡ÔñÓÃδżÁªÒ»¿¹½øÐÐϸ°ûÅàÑøÎï»ò×éÖ¯ÇÐÆ¬µÄË«ÖØ**ȾɫҪÇóÒ»¿¹À´Ô´ÓÚ²»Í¬ÎïÖÖ²¢ÇÒ¶þ¿¹·Ö±ðʶ±ðÆäÖÐÖ®Ò»£¬¶þ¿¹ËµÃ÷ÊéÓ¦ÃèÊöÆäÓëÆäËüÎïÖÖÀ´Ô´µÄ**Çòµ°ÓзñÓн»²æÎü¸½¡£
ºÏ¸ñ Phospho-PDPK1(Ser393) Á×Ëữ3Á×Ëἡ´¼ÒÀÀµÐÔµ°°×¼¤Ã¸1¿¹Ìå
ºÏ¸ñ phospho-PIK3R1(Tyr368) Á×ËữÁ×Ö¬õ£¼¡´¼¼¤Ã¸¿¹Ìå
ºÏ¸ñ Phospho-Paxillin(Tyr88) Á×Ëữ׮µ°°×Paxillin¿¹Ìå
ºÏ¸ñ phospho-AMPK alpha-1 (Thr183) Á×ËữÏÙÜÕµ¥Á×Ëá»î»¯µ°°×¼¤Ã¸¦Á1¿¹Ìå
ºÏ¸ñ phospho-PTPN7 (Ser246) Á×Ëữ·ÇÊÜÌåÐ͵°°×ÀÒ°±ËáÁ×Ëáø7¿¹Ìå
ºÏ¸ñ ºÏ¸ñ phospho-PKC delta (Ser645) Á×Ëữµ°°×¼¤Ã¸CÑÇÐÔDÐÍ¿¹Ìå
ºÏ¸ñ phospho-PRKD3(Ser41) Á×Ëữµ°°×¼¤Ã¸C nuÐÍ¿¹Ìå
ºÏ¸ñ phospho-PTPN6(Tyr564) Á×Ëữµ°°×ÀÒ°±ËáÁ×Ëáø1C¿¹Ìå
ºÏ¸ñ phospho-PTPN6(Ser591) Á×Ëữµ°°×ÀÒ°±ËáÁ×Ëáø1C¿¹Ìå
ºÏ¸ñ phospho-PIK3R2 (Tyr467) Á×ËữÁ×Ö¬õ£¼¡´¼¼¤Ã¸p85¦Â¿¹Ìå
ºÏ¸ñ phospho-PRKCQ (Ser695) Á×Ëữµ°°×¼¤Ã¸C theta¿¹Ìå
ºÏ¸ñ ºÏ¸ñ phospho-14-3-3 epsilon (Thr232) Á×Ëữ14-3-3Eµ°°×¿¹Ìå
ºÏ¸ñ ºÏ¸ñ phospho-P53(Thr55) Á×ËữÖ×ÁöÒÖÖÆ»ùÒòP53¿¹Ìå
ºÏ¸ñ phospho-TNIK (Ser764) Á×ËữTRAF2ºÍNCK¼¤Ã¸Ï໥×÷Óõ°°×¿¹Ìå
ºÏ¸ñ phospho-TERT(Ser1125) Á×Ëữ¶ËÁ£Ã¸Äæ×ªÂ¼Ã¸¿¹Ìå
ºÏ¸ñ Phospho-Tuberin(Ser1418) Á×Ëữ½á½ÚÐÔÓ²»¯µ°°×¿¹Ìå
ºÏ¸ñ Phospho-Smad3 (Ser425) Á×Ëữϸ°ûÐźÅתµ¼·Ö×ÓSMAD3¿¹Ìå
ºÏ¸ñ phospho-Alpha synuclein (Tyr136) Á×ËữºËÍ»´¥µ°°×¦Á¿¹Ìå
ºÏ¸ñ phospho-Alpha synuclein(Ser129) Á×ËữºËÍ»´¥µ°°×¦Á¿¹Ìå
ºÏ¸ñ phospho-SYN1(Ser62+Ser67) Á×ËữÉñ¾Í»´¥ËØ1¿¹Ìå